Combination chemotherapy with weekly docetaxel and estramustine for hormone refractory prostate cancer in Japanese patients.

MLA

Takenaka, Atsushi, et al. “Combination Chemotherapy with Weekly Docetaxel and Estramustine for Hormone Refractory Prostate Cancer in Japanese Patients.” International Journal of Urology, vol. 15, no. 1, Jan. 2008, pp. 106–09. EBSCOhost, https://doi.org/10.1111/j.1442-2042.2007.01929.x.

APA

Takenaka, A., Yamada, Y., Kurahashi, T., Soga, H., Miyake, H., & Fujisawa, M. (2008). Combination chemotherapy with weekly docetaxel and estramustine for hormone refractory prostate cancer in Japanese patients. International Journal of Urology, 15(1), 106–109. https://doi.org/10.1111/j.1442-2042.2007.01929.x

Chicago

Takenaka, Atsushi, Yuji Yamada, Toshifumi Kurahashi, Hideo Soga, Hideaki Miyake, and Masato Fujisawa. 2008. “Combination Chemotherapy with Weekly Docetaxel and Estramustine for Hormone Refractory Prostate Cancer in Japanese Patients.” International Journal of Urology 15 (1): 106–9. doi:10.1111/j.1442-2042.2007.01929.x.